Name: ACAD Nuplazid Approval
Start: 2026-04-27

ACADIA PHARMS INC

Approval Confirmed

Nuplazid

Resolved

71days ago

Approval decision · Apr 27, 2026

What's at stake A final FDA approval decision on Nuplazid for its lead indication is expected Apr 27, 2026.

Primary source · openFDA verified 16h ago

“FDA approved Nuplazid (NDA207318) — sponsor ACADIA PHARMS INC; efficacy supplement (Efficacy); FDA action date 2026-04-27.”

NDA207318 efficacy supplement (Efficacy)

1 source on file.

Link copied ✓